← All stocks

Bioventus Inc.

BVS Net buying
CIK 0001665988 #2414 in the set updated 17 Sep 2026
Bought (120 mo)
$8.39M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.80M
$1.08M on a plan · $0.00 straight out of an exercise
Sold at will
$1.72M
18 of 47 sales
Net
+$5.59M
+$6.67M against sales at will

By person

21 insiders · 73 transactions
1.4×

Robert E. Claypoole holds only 1.4 times base salary in stock. $1.19M of shares against $824.11K in salary for 2025.

Salary from the company's own proxy. The shares are what Robert E. Claypoole last reported holding, valued at $8.79, the price Class A Common Stock was last bought or sold at on the open market here, on 11 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Bartholdson John A.
Director
$6.60M (11)
+$6.60M
7,051,259
$61.96M
+53.5%
Juniper Investment Company, LLC entity
10% owner
$799.91K (3)
+$799.91K
6,833,857
$60.05M
+2.7%
Nosenzo John
Fmr. Chief Commercial Officer
$6.50K (1)
$741.15K (5)
−$734.65K
87,648
$770.13K
D'Adamio Anthony
SVP & General Counsel
$13.00K (1)
$484.08K (11) scheduled
−$471.08K
154,655
$1.36M
Bihl Anthony P III
Interim CEO
$456.06K (3)
+$456.06K
164,885
$1.45M
Singleton Mark Leonard
SVP & CFO
$450.40K (9) scheduled
−$450.40K
177,333
$1.56M
Pavesio Alessandra
Fmr. SVP & Chief Science Off.
$13.00K (1)
$373.62K (2)
−$360.62K
149,309
$1.31M
Claypoole Robert E
President and CEO
$261.95K (1) scheduled
−$261.95K
135,944
$1.19M
McMurry-Heath Michelle
Director
$236.69K (2)
−$236.69K
77,279
$679.02K
HAWKINS WILLIAM A
Director
$235.57K (2)
+$235.57K
297,640
$2.62M
Reali Kenneth Michael
Chief Executive Officer
$148.53K (2)
$13.62K (1)
+$134.91K
39,460
$346.72K
+320.9%
CHURCH KATRINA J
SVP & Chief Compliance Officer
$32.50K (1)
$144.44K (14) scheduled
−$111.94K
66,664
$585.75K
+544.3%
NOHRA GUY P
Director
$75.66K (1)
−$75.66K
148,892
$1.31M
Anglum Gregory O.
SVP & CFO
$78.00K (1)
$15.52K (1)
+$62.48K
61,013
$536.10K
Vizirgianakis Stavros G.
Director
2,781,888
$24.44M
STALNECKER SUSAN M
Director
138,239
$1.21M
NEELS GUIDO J
Director
117,523
$1.03M
SUTTER MARTIN P
Director
117,523
$1.03M
Ladone Mary Kay
Director
111,263
$977.62K
Beyer Pat
Director
108,718
$955.26K
Cowdy Philip G.
Director
43,982
$386.45K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
McMurry-Heath Michelle
11 Mar 2026
Director
Sell
12,000
$8.79
$105.44K
NOHRA GUY P
4 Dec 2025
Director
Sell
10,000
$7.57
$75.66K
McMurry-Heath Michelle
7 Nov 2025
Director
Sell
17,701
$7.42
$131.25K
Singleton Mark Leonard
22 Mar 2024
SVP & CFO
Sell
5,541
$5.39
$29.85K
CHURCH KATRINA J
15 Mar 2024
SVP & Chief Compliance Officer
Sell
1,217
$5.46
$6.64K
D'Adamio Anthony
15 Mar 2024
SVP & General Counsel
Sell
3,125
$5.46
$17.06K
CHURCH KATRINA J
3 Jul 2023
SVP & Chief Compliance Officer
Sell
394
$2.83
$1.12K
Singleton Mark Leonard
24 Mar 2023
SVP & CFO
Sell
6,044
$1.27
$7.68K
CHURCH KATRINA J
15 Mar 2023
SVP & Chief Compliance Officer
Sell
1,332
$1.39
$1.85K
Reali Kenneth Michael
15 Mar 2023
Chief Executive Officer
Sell
9,811
$1.39
$13.62K
D'Adamio Anthony
15 Mar 2023
SVP & General Counsel
Sell
3,409
$1.39
$4.74K
Pavesio Alessandra
4 Apr 2022
SVP & Chief Science Officer
Sell
32,997
$11.17
$368.42K
Nosenzo John
4 Apr 2022
Chief Commercial Officer
Sell
65,963
$11.12
$733.50K
D'Adamio Anthony
4 Apr 2022
SVP & General Counsel
Sell
16,016
$11.19
$179.24K
Nosenzo John
14 Feb 2022
Chief Commercial Officer
Sell
534
$11.99
$6.40K
Anglum Gregory O.
14 Feb 2022
SVP & CFO
Sell
1,294
$11.99
$15.52K
D'Adamio Anthony
14 Feb 2022
SVP & General Counsel
Sell
1,294
$11.99
$15.51K
Pavesio Alessandra
14 Feb 2022
SVP & Chief Science Officer
Sell
433
$11.99
$5.19K

What was left out

Form 4 filings counted 218
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 29
Sales straight out of an exercise 0
Sales at will 18
Transactions with no price 0
Shares from compensation/vesting 5,582,044
Sales filed before the plan box existed 10
History held since 16 Feb 2021